Skip to content
Catalyst

glycineFinding

Glycine decreases glycated haemoglobin (HbA1c)

lowersVery limited evidenceFinding

01 · The sentence it was drawn from

“A1C levels of patients given glycine were significantly lower after 3 months of treatment than those of the placebo group.”
Quoted verbatim from Glycine treatment decreases proinflammatory cytokines and increases interferon-gamma in patients with type 2 diabetes.
This finding among the 64 findings on its endpoint

glycine

Glycated haemoglobin (HbA1c)

lowers

Who
Patients with type 2 diabetes, mean age 58.5 years, mean baseline A1C 8%
Dose studied
5 g/d glycine, po tid, for 3 months

Very limited evidencePMID 18852529 · 2008

02 · The study

Study
RCT
Duration
3 months

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6ZK953ZF1BSQM4EG5APYA8T